The Advocacy Training SessionThe training for certification includes a
|
The Advocacy Training SessionThe training for certification includes a
|
Chair: Dr. P. Kishore, MD, MPH, CMA (Boston NAMA) Committee Members Paul Bowman, CMA Cheri Jarvis, CMA The HCV Committee was created to empower methadone patients through education and advocacy and to provide support for those that do test positive for Hepatitis C. What Is Hepatitis C? Hepatitis is an inflammation of the liver. Although…
Education Series Number 4 April 1994 Herman Joseph, Ph.D. was part of the original team that started methadone treatment at The Rockefeller University. His research and publications have had a major influence on methadone treatment. After leaving the research team at Rockefeller University Dr. Joseph started and administered a methadone clinic for patients on probation…
Friday, September 25, 1998 9 a.m. to 5 p.m. Several countries are using opiates for maintenance treatment, including: * codeine * morphine * palfium * buprenorphine * injectable methadone Presenters of these pharmacotherapies will include leading clinicians and health officials from…
Award Discussion At Joycelyn Wood’s table waiting for the Banquet to start Gary Nessenbaum, Judith Ostergard and Donna Schoen talk about the conference (l to r) The Nyswander -Dole Award Fondly called “The Marie” after Dr. Nyswander the Dole – Nyswander Award was first presented in 1983 to recognize extraordinary work in the field. Recipients…
Note On This Page Admission Requirements Homes Take Home Exceptions (a) The Food and Drug Administration and the Drug Enforcement Administration recognize that the investigational use of methadone requiring the prolonged maintenance of narcotic dependence as part of a total treatment effort has shown promise in the management and rehabilitation of selected narcotic addicts. It…
Numerous studies have shown that dose is one of the most important aspects of methadone treatment and that patients who are given an adequate dose, know their dose and have some influence regarding their dose do better in treatment and remain in treatment (Ball and Ross, 1994; Caplehorn and Bell, 1991; Cooper, 1992; D’Annuno and…